Saturday, February 2, 2013

Twitter says hackers compromise 250K accounts

SAN FRANCISCO (AP) ? The social media giant Twitter acknowledged that it has become the latest victim in a number of cyber-attacks against media companies, saying hackers may have gained access to information on 250,000 of its more than 200 million active users.

The company said a blog post on Friday it detected attempts to gain access to its user data earlier in the week. It shut down one attack moments after it was detected.

But Twitter discovered that the attackers may have stolen user names, email addresses and encrypted passwords belonging to 250,000 users they describe as 'a very small percentage of our users."

Nonetheless, the company reset the pilfered passwords and sent emails advising the affected users.

The online attack comes on the heels of recent hacks into the computer systems of U.S. media and technology companies, including The New York Times and The Wall Street Journal. Both American newspapers reported this week that their computer systems had been infiltrated by China-based hackers, likely to monitor media coverage the Chinese government deems important.

China has been accused of mounting a widespread, aggressive cyber-spying campaign for several years, trying to steal classified information and corporate secrets and to intimidate critics. The Chinese foreign ministry could not be reached for comment Saturday, but the Chinese government has said those accusations are baseless and that China itself is a victim of cyber-attacks.

"Chinese law forbids hacking and any other actions that damage Internet security," the Chinese Defense Ministry recently said. "The Chinese military has never supported any hacking activities."

Although Bob Lord, Twitter's director of information security said in the blog that the attack "was not the work of amateurs, and we do not believe it was an isolated incident."

"The attackers were extremely sophisticated, and we believe other companies and organizations have also been recently similarly attacked," Lord said. "For that reason we felt that it was important to publicize this attack while we still gather information, and we are helping government and federal law enforcement in their effort to find and prosecute these attackers to make the Internet safer for all users."

One expert said that the Twitter hack probably happened after an employee's home or work computer was compromised through vulnerabilities in Java, a commonly used computing language whose weaknesses have been well publicized.

Ashkan Soltani, an independent privacy and security researcher, said such a move would give attackers "a toehold" in Twitter's internal network, potentially allowing them either to sniff out user information as it traveled across the company's system or break into specific areas, such as the authentication servers that process users' passwords.

In a telephone interview Friday, Soltani said that the relatively small number of users affected suggested either that attackers weren't on the network long or that they were only able to compromise a subset of the company's servers.

Twitter is generally used to broadcast messages to the public, so the hacking might not immediately have yielded any important secrets. But the stolen credentials could be used to eavesdrop on private messages or track which Internet address a user is posting from.

That might be useful, for example, for an authoritarian regime trying to keep tabs on a journalist's movements.

"More realistically, someone could use that as an entry point into another service," Soltani said, noting that since few people bother using different passwords for different services, a password stolen from Twitter might be just as handy for reading a journalist's emails.

___

AP reporters Raphael Satter in London and Didi Tang in Beijing contributed to this report.

Source: http://news.yahoo.com/twitter-says-hackers-compromise-250k-accounts-011810359--finance.html

ok go peyton manning super bowl nsx chad ochocinco roman numerals superbowl halftime madonna

Turkey: US Embassy bomber had terror conviction

ANKARA, Turkey (AP) ? The suicide bomber who struck the U.S. Embassy in Ankara spent several years in prison on terrorism charges but was released on probation after being diagnosed with a hunger strike-related brain disorder, officials said Saturday.

The bomber, identified as 40-year-old leftist militant Ecevit Sanli, killed himself and a Turkish security guard on Friday, in what U.S. officials said was a terrorist attack. Sanli was armed with enough TNT to blow up a two-story building and also detonated a hand grenade, officials said.

Sanli had fled Turkey after he was released from jail in 2001, but managed to come back to the country "illegally," using a fake ID, Interior Muammer Guler said. It was not clear how long before the attack he returned to Turkey.

Sanli had been a member of the outlawed Revolutionary People's Liberation Party-Front, or DHKP-C, which has claimed responsibility for assassinations and bombings since the 1970s but has been relatively quiet in recent years. Compared to al-Qaida, it has not been seen as a strong terrorist threat.

Sanli's motives were still unclear. But some Turkish government officials have linked the attack to the arrest last month of dozens of suspected members of the group in a nationwide sweep.

Speculation has also abounded that the bombing was related to the perceived support of the U.S. for Turkey's harsh criticism of the regime in Syria, whose brutal civil war has forced tens of thousands of Syrian refugees to seek shelter in Turkey. But Turkish Prime Minister Recep Tayyip Erdogan has denied that.

Officials said Sanli was arrested in 1997 for alleged involvement in attacks on Istanbul's police headquarters and a military guesthouse and jailed on charges of membership in the group.

While in prison awaiting trial, he took part in a major hunger strike that led to the deaths of dozens of inmates, according to a statement from the Ankara governor's office. The protesters opposed a maximum-security system in which prisoners were held in small cells instead of large wards.

Sanli was diagnosed with Wernicke-Korsakoff syndrome and released on probation in 2001, following the introduction of legislation that allowed hunger strikers with the disorder to get appropriate treatment. The syndrome is a malnutrition-related brain illness that affects vision, muscle coordination and memory and that can cause hallucinations.

Sanli fled Turkey after his release and was wanted by Turkish authorities. He was convicted in absentia in 2002.

The U.S. flag at the embassy flew at half-staff on Saturday and already tight security was increased. Police sealed off a street in front of the security checkpoint where the explosion knocked a door off its hinges and littered the road with debris. Police vehicles were parked in streets surrounding the building.

The Ankara governor's office, citing the findings of a bomb squad that inspected the site, said Sanli had used 6 kilograms of TNT for the suicide attack and also detonated a hand grenade. That amount of TNT can demolish "a two-story reinforced building," according to Nihat Ali Ozcan, a terrorism expert at the Ankara-based Economic Policy Research Foundation of Turkey.

Officials had earlier said that the bomber detonated a suicide vest at the checkpoint on the outer perimeter of the compound.

The guard who was killed was standing outside the checkpoint. The U.S. ambassador on Saturday attended his funeral in a town just outside of Ankara.

A Turkish TV journalist was seriously wounded and two other guards had lighter wounds.

DHKP-C's forerunner, Devrimci Sol, or Revolutionary Left, was formed in 1978 as a Marxist group openly opposed to the United States and NATO. It has attacked Turkish, U.S. and other foreign targets since then, including two U.S. military contractors and a U.S. Air Force officer.

The group, designated as a terrorist organization by the United States and other European allies, changed its name to DHKP-C in 1994.

The attack came as NATO deployed six Patriot anti-missile systems to protect ally Turkey from a possible spillover from the civil war raging across the border in Syria. The United States, Netherlands and Germany are each providing two Patriot batteries.

Ozcan, the terrorism expert, said that the Syrian regime, which had backed terrorist groups in Turkey, including autonomy-seeking Kurdish rebels, during the Cold War era and through the 1990s, had recently revived ties with these groups.

As Turkey began to support the Syrian opposition, Syrian President Bashar Assad's regime began to try "rebuilding its ties with these organizations," Ozcan said.

Radikal newspaper reported that the DHKP-C had recently been taking an interest in "regional issues," reviving its anti-American stance and taking on "a more pro-Assad position."

Former U.S. ambassador to Turkey, Ross Wilson, speculated that the masterminds of the embassy bombing may have been partly motivated by U.S.-Turkish policy on Syria.

"A successful attack would embarrass the Turkish government and security forces, and it would have struck at the United States, which is widely ? if wrongly ? thought to have manipulated the Erdogan government into breaking with Bashar al-Assad and supporting efforts to remove him from power," Wilson, director of the Dinu Patriciu Eurasia Center at the Washington-based Atlantic Council, wrote in an analysis.

"That might rekindle public support for the group. Alas for DHPK/C, this seems unlikely," he wrote.

Howard Eissenstat, a Turkey expert at St. Lawrence University in the United States, said the bombing showed that a "relatively isolated and obscure group" still has the capacity to cause havoc.

"They really fall outside of our comfortable narratives," Eissenstat wrote in an email to The Associated Press. "And they do seem to have been left in an ideological time warp. There is something distinctly cult-like about them."

The attack drew quick condemnation from Turkey, the U.S., Britain and other nations, and officials from both Turkey and the U.S. pledged to work together to fight terrorism.

It was the second deadly assault on a U.S. diplomatic post in five months. On Sept. 11, 2012, terrorists attacked a U.S. mission in Benghazi, Libya, killing U.S. Ambassador Chris Stevens and three other Americans. The attackers in Libya were suspected to have ties to Islamist extremists, and one is in custody in Egypt.

U.S. diplomatic facilities in Turkey have been targeted previously by terrorists. In 2008, an attack blamed on al-Qaida-affiliated militants outside the U.S. Consulate in Istanbul left three assailants and three policemen dead.

______

Associated Press writers Ezgi Akin and Burhan Ozbilici and Christopher Torchia in Istanbul contributed to this report.

Source: http://news.yahoo.com/turkey-us-embassy-bomber-had-terror-conviction-093932685.html

whitney houston autopsy dobie gray bruce springsteen grammy nominations lil boosie bobbi kristina brown new edition

White House: Hagel will win Senate confirmation

WASHINGTON (AP) ? The White House on Friday dismissed criticism of Chuck Hagel's hesitant congressional testimony and insisted that it expects the Senate to confirm him as defense secretary.

One day after Hagel was roughed up in a grueling confirmation hearing, White House spokesman Jay Carney said Hagel did a "fine job" and the Obama administration would be stunned if Republicans tried to block the nomination of a decorated Vietnam combat veteran and former two-term GOP senator.

"The president believes Sen. Hagel will make an excellent secretary of defense and that he will be confirmed and he looks forward to working with Sen. Hagel in that position as we continue to advance our national security priorities," Carney told reporters.

If confirmed, Hagel, 66, would be the lone Republican in President Barack Obama's Cabinet, the first Vietnam veteran to be defense secretary and the first enlisted man to take the post.

Hagel seemed ill-prepared under withering cross-examination from Senate Armed Services Committee Republicans in nearly eight hours of testimony. He was repeatedly pressed about past statements and votes on Israel, Iran and nuclear weapons.

Senate Democrats, who hold the majority, continue to stand behind the nomination, and no Democrat has said he or she would vote against the president's pick for his second-term national security team.

But Republican opposition grew on Friday as Missouri Sen. Roy Blunt, a member of the committee; Illinois Sen. Mark Kirk and North Carolina Sen. Richard Burr announced that they would vote against Hagel. About a dozen Republicans have said they will oppose their former colleague and several others have indicated that they are likely to vote no.

So far, Mississippi Sen. Thad Cochran, the top Republican on the Appropriations Committee, is the only Republican to announce his support for Hagel.

Burr said the hearing "confirmed for me many of the concerns I had about the nomination." Kirk said his existing concerns combined with Hagel's testimony were the reason for his opposition.

Blunt said "Hagel's answers before the committee were simply too inconsistent, particularly as they related to Iran and Israel. The idea that we can contain a nuclear Iran and his view that we should not have unilateral sanctions are just wrong and are too dangerous for us to try."

In fact, Hagel corrected his statement about containment of Iran and said all options, including military action, should be on the table to stop Iran from acquiring a nuclear weapon.

While Blunt announced his opposition, he signaled he would not support any effort to block the nomination. Blunt is a member of the GOP leadership team, and his reluctance to wage a filibuster fight is a positive sign for Hagel amid the threat of efforts to block the nomination.

Democrats hold a 14-12 edge on the committee, which could vote as early as Thursday, and a 55-45 advantage in the full Senate. Democrats would need five Republican votes to stop a filibuster, and GOP lawmakers often have spoken about the right of a president to get an up-or-down vote on his nominee.

Carney did not mention Republican Sen. John McCain by name, but he clearly was referring to him when he questioned the "badgering ... over issues like, 'why did you disagree with me over Iraq?' "

"Now somewhat bizarrely, given that we have 66,000 Americans in uniform in Afghanistan, senators yesterday in the hearing for the nomination of a secretary of defense asked very few questions about that active war," Carney said. "Instead they wanted to re-litigate the past. That argument will continue, no doubt."

The nominee's fiercest exchange came with McCain, a fellow Vietnam veteran and onetime close friend over Iraq.

The Arizona Republican pressed Hagel on whether he was right or wrong about his opposition to President George W. Bush's decision to send an extra 30,000 troops to Iraq in 2007 at a point when the war seemed in danger of being lost. Hagel, who voted to authorize military force in Iraq, later opposed the conflict, comparing it to Vietnam and arguing that it shifted the focus from Afghanistan.

"Were you right? Were you correct in your assessment?" McCain asked.

"I would defer to the judgment of history to sort that out," Hagel said as the two men talked over each other.

"The committee deserves your judgment as to whether you were right or wrong about the surge," McCain insisted.

Unable to elicit a simple response, McCain said the record should show that Hagel refused to answer. And he made it clear that he would have the final word ? with his vote, which he said would be influenced by Hagel's refusal to answer yes or no.

"I think history has already made a judgment about the surge, sir, and you're on the wrong side of it," McCain told Hagel.

Source: http://news.yahoo.com/white-house-hagel-win-senate-confirmation-185753402--politics.html

davy jones deep impact miesha tate vs ronda rousey idiocracy usssa baseball alex o loughlin the godfather

Friday, February 1, 2013

Beyonce posts Super Bowl rehearsal tease

By Randee Dawn, TODAY contributor

Sure, the Super Bowl on Sunday will technically pit two of football's greatest in a head-to-head blowout. But for a lot of fans, it's not about the San Francisco 49ers or the Baltimore Ravens -- because we're all on the same team: Team Beyonce!

Thankfully, the singer -- who will headline the halftime event with what promises to be an all-out funky extravaganza -- understands her team's needs: She's now posted a tease that offers a brief glimpse into her planned halftime shenanigans.

Set to her hit song "Countdown," the video looks into the dance-filled rehearsal between Beyonce and her dancers, and is way too brief. But its YouTube title, "Beyonce Super Bowl Halftime Show Rehearsal: Day 1" implies there may be a Day 2, Day 3 ... and so on. So cross fingers that this is not the only insight into the hitmaker's practice sessions.

Of course, that's not all: Check out the photo Beyonce posted online spotlighting her game face and football-gripping abilities.

Still, it doesn't address one of the big questions likely to be on viewers' minds: Will she sing it live, or will she use backing tracks -- as was rumored happened during her performance at President Barack Obama's second inauguration? Anything is possible.

Getty, Reuters, Filmagic

Related content:

Source: http://entertainment.nbcnews.com/_news/2013/01/31/16791045-beyonce-teases-super-bowl-halftime-performance-with-rehearsal-video?lite

ron paul Cnn Electoral Map roseanne barr guy fawkes gary johnson gary johnson walking dead

JOHNNY MANZIEL TRICK SHOT | Weekly World News

JOHNNY MANZIEL TRICK SHOT | Weekly World News

Johnny Manziel teamed with Dude Perfect to make an epic trickshot video.

Johnny Manziel teamed with Dude Perfect to make an epic trick shot video.

He won the Heisman as a freshman and quarterbacked his team to a huge Cotton Bolw victory and now?. he made an incredible trick shot video.

manziel_trickshotB

All-American Johnny Manziel has proven this by partying at casinos, sitting courtside at sporting events a lot, commenting on Manti Te?o girlfriend hoax on twitter (?Mindblown) and now has made a hot viral YouTube video.

Johnny Football created his? trick shot video with YouTube masters ?Dude Perfect.?

Like this:

Be the first to like this.

  • Most Commented
  • Recent Comments

MOST POPULAR

USER PHOTOS

HOT LINKS

WWN ON FACEBOOK

WWN STORE

Weekly World News Store

GET WWN GEAR. GET PROBED FOR FREE!

RNA Fragments May Yield Rapid, Accurate Cancer Diagnosis

A new method to noninvasively diagnose cancer and monitor its progression could eliminate the need for painful and sometimes life-threatening biopsies


Strands of genetic information preserved inside microvesicles, called exosomes, may help scientists diagnose certain forms of cancer and monitor tumor progression. Image: everystockphoto

Fragments of RNA that cells eject in fatty droplets may point the way to a new era of cancer diagnosis, potentially eliminating the need for invasive tests in certain cases.

Cancer tumor cells shed microvesicles containing proteins and RNA fragments, called exosomes, into cerebral spinal fluid, blood, and urine. Within these exosomes is genetic information that can be analyzed to determine the cancer?s molecular composition and state of progression. Researchers at Massachusetts General Hospital discovered that exosomes preserve the genetic information of their parent cells in 2008, however exosomes have not seen widespread clinical testing as a means of cancer diagnosis until now.

?We have never really been able to detect the genetic components of a tumor by blood or spinal fluid,? says Harvard University neurologist Fred Hochberg. ?This is really a new strategy.? He says exosome diagnostic tests could potentially detect and monitor the progression of a wide variety of cancers. He is one of the lead researchers in a multicenter clinical study using new exosomal diagnostic tests developed by New York City-based Exosome Diagnostics to identify a genetic mutation found exclusively in glioma, the most common form of brain cancer.

When treating other forms of cancer, surgeons are able to biopsy tumors to diagnose and monitor the state of the disease. For brain cancers like glioma, however, multiple biopsies can be life threatening. Bob Carter, head of neurosurgery at the University of California, San Diego, says well-preserved RNA in blood and spinal fluid enables researchers to test and monitor for these genetic changes noninvasively.

He says study researchers separate exosomes from bio-fluids with a diagnostic kit and then extract the relevant genomic information. Once the specific cancer mutation is identified, clinicians will periodically draw additional bio-fluids to monitor the mutation levels to determine whether a patient is responding to therapy.??

Whereas Magnetic Resonance Imaging (MRI) is a useful tool, tumors only show up on imaging scans once they are at least one millimeter in diameter and comprise about 100,000 tumor cells. By that time, it may be too late for an early intervention. On the flip side, MRIs can also yield false positives. Hochberg says individuals who have been treated with conventional radiation therapy often have benign residual tissue from dying tumor cells that have been killed by the treatment but which the body has not yet eliminated. This tissue is often mistaken for tumor growth on a MRI scan. ?You would identify to the patient that the drug is not working when in reality it is doing well,? Hochberg says. ?On the other hand, having an easily accessible biomarker for glioma would give you a clear response.?

There are 18 U.S. hospitals participating in the clinical trial, sponsored by the Accelerated Brain Cancer Cure Foundation. Hochberg says study researchers have recruited 41 of 120 patients so far. Preliminary results will be presented in April at the International Society for Extracellular Vesicles Symposium in Boston.

From a technical standpoint I don?t believe there is a barrier,? Carter says. ?This test can certainly be used now, what we are trying to finalize is the sensitivity and specificity of the test.?

Exosomes may be a reliable method of screening for prostate cancer as well. A PSA test is currently the most common, noninvasive means to screen for prostate cancer in the U.S. PSA testing measures for elevated levels of prostate-specific antigen, a protein produced by the prostate gland that is used to liquefy semen in men. The higher a man?s PSA level, the more likely it is that he has prostate cancer, says James McKiernan, director of urologic oncology at Columbia University Medical Center. There are additional reasons, however, for high PSA levels-and some men with prostate cancer do not always have elevated PSA, he added. In addition, for many cases of prostate cancer, new research published in May 2012 in The New England Journal of Medicine shows that treatment does not actually extend the life of the patient.

Source: http://rss.sciam.com/click.phdo?i=9e0e22dedab48ac09d9793c8ecb86ca6

Jeanie Buss NFL.com NFL playoff schedule 2013 biggest loser Bronson Pelletier andy reid redskins

How cancer cells rewire their metabolism to survive

How cancer cells rewire their metabolism to survive [ Back to EurekAlert! ] Public release date: 31-Jan-2013
[ | E-mail | Share Share ]

Contact: Heather Buschman
hbuschman@sanfordburnham.org
858-795-5343
Sanford-Burnham Medical Research Institute

Sanford-Burnham researchers discover that tumors lacking the protein PKCz are good at surviving when nutrients are scarceopening a new therapeutic avenue that targets cancer metabolism

LA JOLLA, Calif., January 31, 2013 Cancer cells need food to survive and grow. They're very good at getting it, too, even when nutrients are scarce. Many scientists have tried killing cancer cells by taking away their favorite food, a sugar called glucose. Unfortunately, this treatment approach not only fails to work, it backfiresglucose-starved tumors actually get more aggressive. In a study published January 31 in the journal Cell, researchers at Sanford-Burnham Medical Research Institute discovered that a protein called PKC? is responsible for this paradox. The research suggests that glucose depletion therapies might work against tumors as long as the cancer cells are producing PKC?.

PKC?: critical regulator of tumor metabolism

According to this study, when PKC? is missing from cancer cells, tumors are able to use alternative nutrients. What's more, the lower the PKC? levels, the more aggressive the tumor.

"We found an interesting correlation in colon cancersif a patient's tumor doesn't produce PKC?, he has a poorer prognosis than a similar patient with the protein. We looked specifically at colon cancer in this study, but it's likely also true for other tumor types," said Jorge Moscat, Ph.D., a professor in Sanford-Burnham's National Cancer Institute-designated Cancer Center. Moscat led the study in close collaboration with Sanford-Burnham colleague Maria Diaz-Meco, Ph.D.

PKC? keeps tumors addicted to glucose, and under control

Although most cancer cells love glucose, tumors lacking PKC? grow even better in the absence of this nutrient. Using human tumor samples and a mouse model of colon cancer, Moscat and his team determined this growth-without-glucose paradox is because PKC?-deficient tumors are able to reprogram their metabolism to use glutamine, another nutrient, instead.

Without PKC? around to keep them addicted to glucose, these tumors kick-start a new metabolic pathway. This altered metabolism helps PKC?-deficient cancer cells survive in conditions that would otherwise be lethal.

"If we can find an effective way to add PKC? back to tumors that lack it, we'd make them less suited for survival and more sensitive to current therapies," Moscat said.

###

This study was funded by the U.S. National Institutes of HealthNational Cancer Institute grants R01CA132847, R01CA134530, R21CA147978 and 5P30CA030199-31; National Institute of Allergy and Infectious Diseases grant R01AI072581; and National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK088107.

The study was co-authored by Li Ma, Sanford-Burnham; Yongzhen Tao, Sanford-Burnham; Angeles Duran, Sanford-Burnham; Victoria Llado, Sanford-Burnham; Anita Galvez, University of Cincinnati Medical College; Jennifer F.Barger, University of Cincinnati Medical College; Elias A. Castilla, University of Cincinnati Medical College; Jing Chen, University of Cincinnati Medical College; Tomoko Yajima, Sanford-Burnham; Aleksey Porollo, University of Cincinnati Medical College; Mario Medvedovic, University of Cincinnati Medical College; Laurence M. Brill, Sanford-Burnham; David R. Plas, University of Cincinnati Medical College; Stefan J. Riedl, Sanford-Burnham; Michael Leitges, University of Oslo; Maria T. Diaz-Meco, Sanford-Burnham; Adam D. Richardson, Sanford-Burnham; and Jorge Moscat, Sanford-Burnham.

About Sanford-Burnham Medical Research Institute

Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. The Institute consistently ranks among the top five organizations worldwide for its scientific impact in the fields of biology and biochemistry (defined by citations per publication) and currently ranks third in the nation in NIH funding among all laboratory-based research institutes. Sanford-Burnham utilizes a unique, collaborative approach to medical research and has established major research programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory and childhood diseases. The Institute is especially known for its world-class capabilities in stem cell research and drug discovery technologies. Sanford-Burnham is a U.S.-based, nonprofit public benefit corporation, with operations in San Diego (La Jolla), California and Orlando (Lake Nona), Florida. For more information, news and events, please visit us at sanfordburnham.org.


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


How cancer cells rewire their metabolism to survive [ Back to EurekAlert! ] Public release date: 31-Jan-2013
[ | E-mail | Share Share ]

Contact: Heather Buschman
hbuschman@sanfordburnham.org
858-795-5343
Sanford-Burnham Medical Research Institute

Sanford-Burnham researchers discover that tumors lacking the protein PKCz are good at surviving when nutrients are scarceopening a new therapeutic avenue that targets cancer metabolism

LA JOLLA, Calif., January 31, 2013 Cancer cells need food to survive and grow. They're very good at getting it, too, even when nutrients are scarce. Many scientists have tried killing cancer cells by taking away their favorite food, a sugar called glucose. Unfortunately, this treatment approach not only fails to work, it backfiresglucose-starved tumors actually get more aggressive. In a study published January 31 in the journal Cell, researchers at Sanford-Burnham Medical Research Institute discovered that a protein called PKC? is responsible for this paradox. The research suggests that glucose depletion therapies might work against tumors as long as the cancer cells are producing PKC?.

PKC?: critical regulator of tumor metabolism

According to this study, when PKC? is missing from cancer cells, tumors are able to use alternative nutrients. What's more, the lower the PKC? levels, the more aggressive the tumor.

"We found an interesting correlation in colon cancersif a patient's tumor doesn't produce PKC?, he has a poorer prognosis than a similar patient with the protein. We looked specifically at colon cancer in this study, but it's likely also true for other tumor types," said Jorge Moscat, Ph.D., a professor in Sanford-Burnham's National Cancer Institute-designated Cancer Center. Moscat led the study in close collaboration with Sanford-Burnham colleague Maria Diaz-Meco, Ph.D.

PKC? keeps tumors addicted to glucose, and under control

Although most cancer cells love glucose, tumors lacking PKC? grow even better in the absence of this nutrient. Using human tumor samples and a mouse model of colon cancer, Moscat and his team determined this growth-without-glucose paradox is because PKC?-deficient tumors are able to reprogram their metabolism to use glutamine, another nutrient, instead.

Without PKC? around to keep them addicted to glucose, these tumors kick-start a new metabolic pathway. This altered metabolism helps PKC?-deficient cancer cells survive in conditions that would otherwise be lethal.

"If we can find an effective way to add PKC? back to tumors that lack it, we'd make them less suited for survival and more sensitive to current therapies," Moscat said.

###

This study was funded by the U.S. National Institutes of HealthNational Cancer Institute grants R01CA132847, R01CA134530, R21CA147978 and 5P30CA030199-31; National Institute of Allergy and Infectious Diseases grant R01AI072581; and National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK088107.

The study was co-authored by Li Ma, Sanford-Burnham; Yongzhen Tao, Sanford-Burnham; Angeles Duran, Sanford-Burnham; Victoria Llado, Sanford-Burnham; Anita Galvez, University of Cincinnati Medical College; Jennifer F.Barger, University of Cincinnati Medical College; Elias A. Castilla, University of Cincinnati Medical College; Jing Chen, University of Cincinnati Medical College; Tomoko Yajima, Sanford-Burnham; Aleksey Porollo, University of Cincinnati Medical College; Mario Medvedovic, University of Cincinnati Medical College; Laurence M. Brill, Sanford-Burnham; David R. Plas, University of Cincinnati Medical College; Stefan J. Riedl, Sanford-Burnham; Michael Leitges, University of Oslo; Maria T. Diaz-Meco, Sanford-Burnham; Adam D. Richardson, Sanford-Burnham; and Jorge Moscat, Sanford-Burnham.

About Sanford-Burnham Medical Research Institute

Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. The Institute consistently ranks among the top five organizations worldwide for its scientific impact in the fields of biology and biochemistry (defined by citations per publication) and currently ranks third in the nation in NIH funding among all laboratory-based research institutes. Sanford-Burnham utilizes a unique, collaborative approach to medical research and has established major research programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory and childhood diseases. The Institute is especially known for its world-class capabilities in stem cell research and drug discovery technologies. Sanford-Burnham is a U.S.-based, nonprofit public benefit corporation, with operations in San Diego (La Jolla), California and Orlando (Lake Nona), Florida. For more information, news and events, please visit us at sanfordburnham.org.


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Source: http://www.eurekalert.org/pub_releases/2013-01/smri-hcc013013.php

Malware Monday First Row Sports American flag Happy 4th of July 4th Of July Desserts fireworks fireworks